Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 20Neoplasm Metastasis 13Liver Neoplasms 8Colorectal Neoplasms 7Lung Neoplasms 6Cholangiocarcinoma 6Pancreatic Neoplasms 5Rectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Barrett Esophagus 4Recurrence 3Pain 3Biliary Tract Neoplasms 3Prostatic Neoplasms 2Leiomyoma 2Kidney Neoplasms 2Esophageal Neoplasms 2Breast Neoplasms 2Thyroid Cancer, Papillary 1Thymoma 1Squamous Intraepithelial Lesions 1Small Cell Lung Carcinoma 1Pancreatic cancer, adult 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Micrometastasis 1Myoma 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6Uterine Artery Embolization 5Norethindrone Acetate 5relugolix 4Uterine Myomectomy 3linzagolix 2Tranexamic Acid 2ziprasidone 1vilaprisan 1ulipristal 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Radiofrequency Ablation 1Progesterone 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Menorrhagia × Radiofrequency Ablation × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡